Merck, Viatris settle patent dispute over Januvia
AdminMerck, Viatris settle patent dispute over Januvia Source link
Viatris goes ex-dividend tomorrow
Viatris goes ex-dividend tomorrow Source link
Viatris joins AbbVie and Lilly in protesting against U.K. drug pricing deal (NASDAQ:VTRS)
Oleksandr Siedov/iStock via Getty Images Viatris (NASDAQ:VTRS) has become the latest drugmaker to voice opposition to changes to the U.K. voluntary medicines pricing agreement after its U.S. rivals AbbVie (ABBV)…
BioAtla President to Leave for Become CEO of Viatris By Investing.com
BioAtla (BCAB) President to Leave for Become CEO of Viatris BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics…